Hillstream BioPharma, Inc. (NASDAQ:HILS) today announced that it has regained compliance with the Nasdaq listing minimum bid price requirement for continued listing on the Nasdaq Capital Market exchange.
Hillstream BioPharma Regained Compliance With Nasdaq Listing Minimum Bid Price Rule
Hillstream BioPharma, Inc. (NASDAQ: HILS) today announced that it has regained compliance with the Nasdaq listing minimum bid price requirement for continued listing on the Nasdaq Capital Market exchange.
Related Posts
Coeur Mining Upgraded: Analyst Dives Deep Into Prospects Of Rochester Mine In Nevada
RBC Capital Markets analyst Michael Siperco upgraded Coeur Mining, Inc (NYSE: CDE) from Sector Perform to Outperform,